Affordable Access

Access to the full text

Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration

  • Woollacott, Ione O. C.1
  • Toomey, Christina E.2, 1
  • Strand, Catherine2
  • Courtney, Robert2
  • Benson, Bridget C.2, 1
  • Rohrer, Jonathan D.1
  • Lashley, Tammaryn2, 1
  • 1 UCL Queen Square Institute of Neurology, London, UK , London (United Kingdom)
  • 2 UCL Queen Square Institute of Neurology, 1 Wakefield Street, London, WC1N 1PJ, UK , London (United Kingdom)
Published Article
Journal of Neuroinflammation
Springer (Biomed Central Ltd.)
Publication Date
Aug 10, 2020
DOI: 10.1186/s12974-020-01907-0
Springer Nature


BackgroundMicroglial dysfunction is implicated in frontotemporal lobar degeneration (FTLD). Although studies have reported excessive microglial activation or senescence (dystrophy) in Alzheimer’s disease (AD), few have explored this in FTLD. We examined regional patterns of microglial burden, activation and dystrophy in sporadic and genetic FTLD, sporadic AD and controls.MethodsImmunohistochemistry was performed in frontal and temporal grey and white matter from 50 pathologically confirmed FTLD cases (31 sporadic, 19 genetic: 20 FTLD-tau, 26 FTLD-TDP, four FTLD-FUS), five AD cases and five controls, using markers to detect phagocytic (CD68-positive) and antigen-presenting (CR3/43-positive) microglia, and microglia in general (Iba1-positive). Microglial burden and activation (morphology) were assessed quantitatively for each microglial phenotype. Iba1-positive microglia were assessed semi-quantitatively for dystrophy severity and qualitatively for rod-shaped and hypertrophic morphology. Microglia were compared in each region between FTLD, AD and controls, and between different pathological subtypes of FTLD, including its main subtypes (FTLD-tau, FTLD-TDP, FTLD-FUS), and subtypes of FTLD-tau, FTLD-TDP and genetic FTLD. Microglia were also compared between grey and white matter within each lobe for each group.ResultsThere was a higher burden of phagocytic and antigen-presenting microglia in FTLD and AD cases than controls, but activation was often not increased. Burden was generally higher in white matter than grey matter, but activation was greater in grey matter. However, microglia varied regionally according to FTLD subtype and disease mechanism. Dystrophy was more severe in FTLD and AD than controls, and more severe in white than grey matter, but this also varied regionally and was particularly extensive in FTLD due to progranulin (GRN) mutations. Presence of rod-shaped and hypertrophic microglia also varied by FTLD subtype.ConclusionsThis study demonstrates regionally variable microglial involvement in FTLD and links this to underlying disease mechanisms. This supports investigation of microglial dysfunction in disease models and consideration of anti-senescence therapies in clinical trials.

Report this publication


Seen <100 times